InvestorsHub Logo
Followers 5
Posts 809
Boards Moderated 0
Alias Born 08/30/2017

Re: None

Monday, 06/01/2020 9:28:14 AM

Monday, June 01, 2020 9:28:14 AM

Post# of 1739
Shareholders need to remember the drug Metoclopramide is already FDA approve in Pill form and injection. Evoke has submitting a NDA for FDA approval of Metoclopramide in nasal spray form which has been proven in clinical study to be more effective, faster, and safer to treat the symptoms of Diabetic Gastroparesis disease than what is already on the market.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EVOK News